Novel Strategies for Treatment of Early Breast Cancer, Part I – Video




Novel Strategies for Treatment of Early Breast Cancer, Part I
The HER2 biology lends itself to several novel strategies for treating early breast cancer. Debu Triapthy, MD, believes that the dual kinase inhibitor lapatinib seems to be at the forefront of improvements in the adjuvant treatment of breast cancer and holds a great deal of potential. For more from this panel discussion, visit http://www.onclive.comFrom:OncLiveTVViews:3 0ratingsTime:03:33More inEducation

Excerpt from:
Novel Strategies for Treatment of Early Breast Cancer, Part I - Video

Related Posts

Comments are closed.